237 related articles for article (PubMed ID: 28412299)
1. Toll-Like Receptor 4-Independent Carbon Tetrachloride-Induced Fibrosis and Lipopolysaccharide-Induced Acute Liver Injury in Mice: Role of Hepatic Stellate Cells.
Kumar S; Wang J; Shanmukhappa SK; Gandhi CR
Am J Pathol; 2017 Jun; 187(6):1356-1367. PubMed ID: 28412299
[TBL] [Abstract][Full Text] [Related]
2. CD14 is not required for carbon tetrachloride-induced hepatic inflammation and fibrosis with or without lipopolysaccharide challenge.
Sharma A; Wang J; Gandhi CR
J Cell Physiol; 2023 Jul; 238(7):1530-1541. PubMed ID: 37098757
[TBL] [Abstract][Full Text] [Related]
3. Fibromodulin, an oxidative stress-sensitive proteoglycan, regulates the fibrogenic response to liver injury in mice.
Mormone E; Lu Y; Ge X; Fiel MI; Nieto N
Gastroenterology; 2012 Mar; 142(3):612-621.e5. PubMed ID: 22138190
[TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide mediates hepatic stellate cell activation by regulating autophagy and retinoic acid signaling.
Chen M; Liu J; Yang W; Ling W
Autophagy; 2017; 13(11):1813-1827. PubMed ID: 29160747
[TBL] [Abstract][Full Text] [Related]
5. Babao Dan attenuates hepatic fibrosis by inhibiting hepatic stellate cells activation and proliferation via TLR4 signaling pathway.
Liang L; Yang X; Yu Y; Li X; Wu Y; Shi R; Jiang J; Gao L; Ye F; Zhao Q; Li R; Wei L; Han Z
Oncotarget; 2016 Dec; 7(50):82554-82566. PubMed ID: 27776340
[TBL] [Abstract][Full Text] [Related]
6. A novel mouse model of depletion of stellate cells clarifies their role in ischemia/reperfusion- and endotoxin-induced acute liver injury.
Stewart RK; Dangi A; Huang C; Murase N; Kimura S; Stolz DB; Wilson GC; Lentsch AB; Gandhi CR
J Hepatol; 2014 Feb; 60(2):298-305. PubMed ID: 24060854
[TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide Reverses Hepatic Stellate Cell Activation Through Modulation of cMyb, Small Mothers Against Decapentaplegic, and CCAAT/Enhancer-Binding Protein C/EBP Transcription Factors.
Sharma A; Verma AK; Kofron M; Kudira R; Miethke A; Wu T; Wang J; Gandhi CR
Hepatology; 2020 Nov; 72(5):1800-1818. PubMed ID: 32064648
[TBL] [Abstract][Full Text] [Related]
8. Functional linkage of cirrhosis-predictive single nucleotide polymorphisms of Toll-like receptor 4 to hepatic stellate cell responses.
Guo J; Loke J; Zheng F; Hong F; Yea S; Fukata M; Tarocchi M; Abar OT; Huang H; Sninsky JJ; Friedman SL
Hepatology; 2009 Mar; 49(3):960-8. PubMed ID: 19085953
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of MAPK and NF-κB signaling pathways alleviate carbon tetrachloride (CCl4)-induced liver fibrosis in Toll-like receptor 5 (TLR5) deficiency mice.
Shu M; Huang DD; Hung ZA; Hu XR; Zhang S
Biochem Biophys Res Commun; 2016 Feb; 471(1):233-9. PubMed ID: 26845355
[TBL] [Abstract][Full Text] [Related]
10. Toll like receptor 2 knock-out attenuates carbon tetrachloride (CCl4)-induced liver fibrosis by downregulating MAPK and NF-κB signaling pathways.
Ji L; Xue R; Tang W; Wu W; Hu T; Liu X; Peng X; Gu J; Chen S; Zhang S
FEBS Lett; 2014 Jun; 588(12):2095-100. PubMed ID: 24815695
[TBL] [Abstract][Full Text] [Related]
11. ECM1 Prevents Activation of Transforming Growth Factor β, Hepatic Stellate Cells, and Fibrogenesis in Mice.
Fan W; Liu T; Chen W; Hammad S; Longerich T; Hausser I; Fu Y; Li N; He Y; Liu C; Zhang Y; Lian Q; Zhao X; Yan C; Li L; Yi C; Ling Z; Ma L; Zhao X; Xu H; Wang P; Cong M; You H; Liu Z; Wang Y; Chen J; Li D; Hui L; Dooley S; Hou J; Jia J; Sun B
Gastroenterology; 2019 Nov; 157(5):1352-1367.e13. PubMed ID: 31362006
[TBL] [Abstract][Full Text] [Related]
12. Caffeic acid phenethyl ester attenuates pro-inflammatory and fibrogenic phenotypes of LPS-stimulated hepatic stellate cells through the inhibition of NF-κB signaling.
Zhao WX; Wang L; Yang JL; Li LZ; Xu WM; Li T
Int J Mol Med; 2014 Mar; 33(3):687-94. PubMed ID: 24378685
[TBL] [Abstract][Full Text] [Related]
13. A lncRNA Gpr137b-ps/miR-200a-3p/CXCL14 axis modulates hepatic stellate cell (HSC) activation.
Liao J; Zhang Z; Yuan Q; Liu Q; Kuang J; Fang Y; Hu X
Toxicol Lett; 2021 Jan; 336():21-31. PubMed ID: 33069761
[TBL] [Abstract][Full Text] [Related]
14. Thrombin cleavage of osteopontin controls activation of hepatic stellate cells and is essential for liver fibrogenesis.
Cui G; Chen J; Wu Z; Huang H; Wang L; Liang Y; Zeng P; Yang J; Uede T; Diao H
J Cell Physiol; 2019 Jun; 234(6):8988-8997. PubMed ID: 30350863
[TBL] [Abstract][Full Text] [Related]
15. Mogroside IVE attenuates experimental liver fibrosis in mice and inhibits HSC activation through downregulating TLR4-mediated pathways.
Cao F; Zhang Y; Li W; Shimizu K; Xie H; Zhang C
Int Immunopharmacol; 2018 Feb; 55():183-192. PubMed ID: 29268190
[TBL] [Abstract][Full Text] [Related]
16. Xia-yu-xue decoction (XYXD) reduces carbon tetrachloride (CCl4)-induced liver fibrosis through inhibition hepatic stellate cell activation by targeting NF-κB and TGF-β1 signaling pathways.
Liu C; Yuan X; Tao L; Cheng Z; Dai X; Sheng X; Xue D
BMC Complement Altern Med; 2015 Jun; 15():201. PubMed ID: 26122378
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-146a-5p Negatively Regulates Pro-Inflammatory Cytokine Secretion and Cell Activation in Lipopolysaccharide Stimulated Human Hepatic Stellate Cells through Inhibition of Toll-Like Receptor 4 Signaling Pathways.
Chen Y; Zeng Z; Shen X; Wu Z; Dong Y; Cheng JC
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399683
[TBL] [Abstract][Full Text] [Related]
18. The inhibition of Hippo/Yap signaling pathway is required for magnesium isoglycyrrhizinate to ameliorate hepatic stellate cell inflammation and activation.
Li L; Zhou J; Li Q; Xu J; Qi J; Bian H
Biomed Pharmacother; 2018 Oct; 106():83-91. PubMed ID: 29957470
[TBL] [Abstract][Full Text] [Related]
19. Aryl Hydrocarbon Receptor Signaling Prevents Activation of Hepatic Stellate Cells and Liver Fibrogenesis in Mice.
Yan J; Tung HC; Li S; Niu Y; Garbacz WG; Lu P; Bi Y; Li Y; He J; Xu M; Ren S; Monga SP; Schwabe RF; Yang D; Xie W
Gastroenterology; 2019 Sep; 157(3):793-806.e14. PubMed ID: 31170413
[TBL] [Abstract][Full Text] [Related]
20. Role of growth factor receptor-bound 2 in CCl
Ge S; Xiong Y; Wu X; Xie J; Liu F; He J; Xiang T; Cheng N; Lai L; Zhong Y
Biomed Pharmacother; 2017 Aug; 92():942-951. PubMed ID: 28618656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
